Résultats de la recherche - 24 results
General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
p.385-94 (2013) Keywords: Animals Clinical Trials as Topic Genetic Therapy Genetic Vectors Hazardous Substances Humans Organisms, Genetically Modified Risk Assessment Vaccination Viruses Abstract: This ...
Establishment of the Ph. Eur. BRP for varicella vaccine batch 1.
Antibodies, Viral Chickenpox Vaccine Europe Freeze Drying Herpesvirus 3, Human Humans Pharmacopoeias as Topic Reference Standards Reproducibility of Results Abstract: The European Pharmacopoeia (Ph. Eur.) ...
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.
Publication Type: Peer reviewed scientific article Authors: Margaux Mi Meslé; Jeremy Brown; Mook, Piers; José Hagan; Roberta Pastore; Nick Bundle; Gianfranco Spiteri; Giovanni Ravasi; Nathalie Nicolay; Nick Andrews; Tetiana Dykhanovska; Mossong, Joel; Mał ...
Phage Biobank: Present Challenges and Future Perspectives.
improve the reproducibility, safety and speed of the provision of suitable phages. Here we discuss the specific characteristics and challenges of a sustainable phage biobank and, as we build a national ...